nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—ADRA1A—polycystic ovary syndrome	0.834	1	CbGaD
Levonordefrin—Methoxamine—ADRA1D—polycystic ovary syndrome	0.00172	0.138	CrCbGaD
Levonordefrin—Methoxamine—ADRA1B—polycystic ovary syndrome	0.00147	0.118	CrCbGaD
Levonordefrin—Methoxamine—ADRA1A—polycystic ovary syndrome	0.000987	0.0793	CrCbGaD
Levonordefrin—Metaraminol—ADRA1A—polycystic ovary syndrome	0.000987	0.0793	CrCbGaD
Levonordefrin—Droxidopa—ADRA1D—polycystic ovary syndrome	0.000549	0.0441	CrCbGaD
Levonordefrin—Droxidopa—ADRB3—polycystic ovary syndrome	0.000493	0.0396	CrCbGaD
Levonordefrin—Droxidopa—ADRA1B—polycystic ovary syndrome	0.000468	0.0376	CrCbGaD
Levonordefrin—Norepinephrine—ADRA1D—polycystic ovary syndrome	0.000462	0.0371	CrCbGaD
Levonordefrin—Isoprenaline—ADRB3—polycystic ovary syndrome	0.000448	0.036	CrCbGaD
Levonordefrin—Epinephrine—ADRA1D—polycystic ovary syndrome	0.000419	0.0337	CrCbGaD
Levonordefrin—Norepinephrine—ADRB3—polycystic ovary syndrome	0.000415	0.0334	CrCbGaD
Levonordefrin—Isoetarine—ADRB2—polycystic ovary syndrome	0.00041	0.033	CrCbGaD
Levonordefrin—Norepinephrine—ADRA1B—polycystic ovary syndrome	0.000394	0.0317	CrCbGaD
Levonordefrin—Epinephrine—ADRB3—polycystic ovary syndrome	0.000376	0.0303	CrCbGaD
Levonordefrin—Epinephrine—ADRA1B—polycystic ovary syndrome	0.000358	0.0288	CrCbGaD
Levonordefrin—Phenylpropanolamine—ADRA1A—polycystic ovary syndrome	0.000343	0.0276	CrCbGaD
Levonordefrin—Salbutamol—ADRB2—polycystic ovary syndrome	0.000317	0.0255	CrCbGaD
Levonordefrin—Droxidopa—ADRA1A—polycystic ovary syndrome	0.000315	0.0253	CrCbGaD
Levonordefrin—Norepinephrine—ADRA1A—polycystic ovary syndrome	0.000265	0.0213	CrCbGaD
Levonordefrin—Epinephrine—ADRA1A—polycystic ovary syndrome	0.000241	0.0194	CrCbGaD
Levonordefrin—Phenylpropanolamine—ADRB2—polycystic ovary syndrome	0.000204	0.0164	CrCbGaD
Levonordefrin—Droxidopa—ADRB2—polycystic ovary syndrome	0.000187	0.0151	CrCbGaD
Levonordefrin—Isoprenaline—ADRB2—polycystic ovary syndrome	0.00017	0.0137	CrCbGaD
Levonordefrin—Norepinephrine—ADRB2—polycystic ovary syndrome	0.000158	0.0127	CrCbGaD
Levonordefrin—Isoprenaline—CYP1A1—polycystic ovary syndrome	0.000146	0.0117	CrCbGaD
Levonordefrin—Epinephrine—ADRB2—polycystic ovary syndrome	0.000143	0.0115	CrCbGaD
Levonordefrin—ADRA2C—Metabolism—AKR1C1—polycystic ovary syndrome	3.96e-05	0.000257	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.94e-05	0.000256	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.93e-05	0.000256	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—POMC—polycystic ovary syndrome	3.93e-05	0.000255	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.91e-05	0.000254	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—HMMR—polycystic ovary syndrome	3.9e-05	0.000253	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.86e-05	0.00025	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—INHBB—polycystic ovary syndrome	3.84e-05	0.000249	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FST—polycystic ovary syndrome	3.83e-05	0.000249	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.81e-05	0.000248	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.79e-05	0.000246	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.78e-05	0.000245	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.76e-05	0.000244	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LHB—polycystic ovary syndrome	3.74e-05	0.000243	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—HSD3B1—polycystic ovary syndrome	3.72e-05	0.000242	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.67e-05	0.000239	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.66e-05	0.000238	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—SULT2A1—polycystic ovary syndrome	3.64e-05	0.000237	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—IGF1—polycystic ovary syndrome	3.62e-05	0.000235	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—AKT2—polycystic ovary syndrome	3.62e-05	0.000235	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.58e-05	0.000233	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FST—polycystic ovary syndrome	3.58e-05	0.000233	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.56e-05	0.000231	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.54e-05	0.00023	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.54e-05	0.00023	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.53e-05	0.00023	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—RRM2—polycystic ovary syndrome	3.53e-05	0.000229	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	3.51e-05	0.000228	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SCT—polycystic ovary syndrome	3.51e-05	0.000228	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LHB—polycystic ovary syndrome	3.49e-05	0.000227	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.49e-05	0.000227	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	3.48e-05	0.000226	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.46e-05	0.000225	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—SERPINE1—polycystic ovary syndrome	3.44e-05	0.000223	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	3.44e-05	0.000223	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.42e-05	0.000222	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.41e-05	0.000222	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—YAP1—polycystic ovary syndrome	3.4e-05	0.000221	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—LHB—polycystic ovary syndrome	3.39e-05	0.000221	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—IGF1—polycystic ovary syndrome	3.38e-05	0.00022	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—AKT2—polycystic ovary syndrome	3.38e-05	0.00022	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.34e-05	0.000217	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—HSD3B2—polycystic ovary syndrome	3.32e-05	0.000216	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.31e-05	0.000215	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.3e-05	0.000214	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.3e-05	0.000214	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FGF18—polycystic ovary syndrome	3.29e-05	0.000214	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SCT—polycystic ovary syndrome	3.27e-05	0.000213	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—NAMPT—polycystic ovary syndrome	3.27e-05	0.000212	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	3.26e-05	0.000212	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RBP4—polycystic ovary syndrome	3.26e-05	0.000212	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.23e-05	0.00021	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP11A1—polycystic ovary syndrome	3.22e-05	0.000209	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AKR1C1—polycystic ovary syndrome	3.21e-05	0.000209	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—SERPINE1—polycystic ovary syndrome	3.21e-05	0.000209	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.21e-05	0.000208	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	3.19e-05	0.000208	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.17e-05	0.000206	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	3.13e-05	0.000203	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.12e-05	0.000203	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.11e-05	0.000202	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.09e-05	0.000201	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FGF18—polycystic ovary syndrome	3.07e-05	0.000199	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.07e-05	0.000199	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	3.05e-05	0.000198	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—AKR1C3—polycystic ovary syndrome	3.05e-05	0.000198	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RBP4—polycystic ovary syndrome	3.04e-05	0.000198	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—YAP1—polycystic ovary syndrome	3.04e-05	0.000198	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GAB1—polycystic ovary syndrome	3e-05	0.000195	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP17A1—polycystic ovary syndrome	3e-05	0.000195	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	3e-05	0.000195	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.99e-05	0.000194	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.98e-05	0.000194	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	2.96e-05	0.000192	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	2.91e-05	0.000189	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.89e-05	0.000188	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.89e-05	0.000188	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.89e-05	0.000187	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.87e-05	0.000187	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—INSR—polycystic ovary syndrome	2.87e-05	0.000186	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	2.86e-05	0.000186	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	2.86e-05	0.000186	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—YAP1—polycystic ovary syndrome	2.84e-05	0.000185	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	2.84e-05	0.000184	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.83e-05	0.000184	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GAB1—polycystic ovary syndrome	2.8e-05	0.000182	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.77e-05	0.00018	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	2.76e-05	0.000179	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	2.75e-05	0.000179	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	2.75e-05	0.000178	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.73e-05	0.000177	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.73e-05	0.000177	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.69e-05	0.000175	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.68e-05	0.000174	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.68e-05	0.000174	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.68e-05	0.000174	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—INSR—polycystic ovary syndrome	2.68e-05	0.000174	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.66e-05	0.000173	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	2.66e-05	0.000173	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PGR—polycystic ovary syndrome	2.66e-05	0.000173	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	2.65e-05	0.000172	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.65e-05	0.000172	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.63e-05	0.000171	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.62e-05	0.00017	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	2.62e-05	0.00017	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	2.61e-05	0.00017	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—TH—polycystic ovary syndrome	2.59e-05	0.000169	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.55e-05	0.000165	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.54e-05	0.000165	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—SLC2A4—polycystic ovary syndrome	2.52e-05	0.000164	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.51e-05	0.000163	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.49e-05	0.000162	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.48e-05	0.000161	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PGR—polycystic ovary syndrome	2.48e-05	0.000161	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	2.47e-05	0.000161	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.47e-05	0.000161	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PLAT—polycystic ovary syndrome	2.47e-05	0.00016	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GHRL—polycystic ovary syndrome	2.47e-05	0.00016	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.45e-05	0.000159	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	2.44e-05	0.000158	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.43e-05	0.000158	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.38e-05	0.000155	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP19A1—polycystic ovary syndrome	2.37e-05	0.000154	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—VEGFA—polycystic ovary syndrome	2.37e-05	0.000154	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ATF1—polycystic ovary syndrome	2.36e-05	0.000153	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	2.34e-05	0.000152	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.31e-05	0.00015	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PLAT—polycystic ovary syndrome	2.31e-05	0.00015	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GHRL—polycystic ovary syndrome	2.31e-05	0.00015	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.3e-05	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.29e-05	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.28e-05	0.000148	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.23e-05	0.000145	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.22e-05	0.000144	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—VEGFA—polycystic ovary syndrome	2.21e-05	0.000144	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ATF1—polycystic ovary syndrome	2.2e-05	0.000143	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.19e-05	0.000142	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	2.18e-05	0.000141	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NGFR—polycystic ovary syndrome	2.17e-05	0.000141	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	2.17e-05	0.000141	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—POMC—polycystic ovary syndrome	2.16e-05	0.00014	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PRL—polycystic ovary syndrome	2.16e-05	0.00014	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.15e-05	0.000139	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.14e-05	0.000139	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GNAS—polycystic ovary syndrome	2.12e-05	0.000138	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—TH—polycystic ovary syndrome	2.11e-05	0.000137	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.08e-05	0.000135	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.07e-05	0.000134	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	2.05e-05	0.000133	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.04e-05	0.000133	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.04e-05	0.000132	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NGFR—polycystic ovary syndrome	2.03e-05	0.000132	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—POMC—polycystic ovary syndrome	2.02e-05	0.000131	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—NCOR1—polycystic ovary syndrome	2.02e-05	0.000131	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	2.02e-05	0.000131	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	2.02e-05	0.000131	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	2.02e-05	0.000131	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PRL—polycystic ovary syndrome	2.01e-05	0.000131	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.94e-05	0.000126	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.94e-05	0.000126	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	1.93e-05	0.000125	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.92e-05	0.000125	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP1A1—polycystic ovary syndrome	1.91e-05	0.000124	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.91e-05	0.000124	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.9e-05	0.000123	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.88e-05	0.000122	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.87e-05	0.000122	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.87e-05	0.000122	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.87e-05	0.000121	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.81e-05	0.000117	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.81e-05	0.000117	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	1.79e-05	0.000117	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.79e-05	0.000116	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—MTHFR—polycystic ovary syndrome	1.78e-05	0.000116	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.78e-05	0.000115	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.77e-05	0.000115	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GNAS—polycystic ovary syndrome	1.77e-05	0.000115	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.76e-05	0.000115	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.76e-05	0.000114	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.74e-05	0.000113	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.74e-05	0.000113	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	1.72e-05	0.000112	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.7e-05	0.00011	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.69e-05	0.00011	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.67e-05	0.000108	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	1.66e-05	0.000108	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.65e-05	0.000107	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.64e-05	0.000106	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	1.64e-05	0.000106	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	1.64e-05	0.000106	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.58e-05	0.000102	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	1.55e-05	0.000101	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.55e-05	0.000101	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.55e-05	0.000101	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.52e-05	9.86e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	1.49e-05	9.65e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.47e-05	9.58e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	1.45e-05	9.41e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.45e-05	9.4e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	1.45e-05	9.39e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.44e-05	9.34e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	1.43e-05	9.26e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	1.42e-05	9.21e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—INS—polycystic ovary syndrome	1.42e-05	9.21e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	1.39e-05	9.02e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.37e-05	8.9e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.34e-05	8.74e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	1.33e-05	8.61e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	1.28e-05	8.29e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	1.27e-05	8.25e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.24e-05	8.05e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	1.24e-05	8.04e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.23e-05	7.98e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.23e-05	7.97e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.21e-05	7.88e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	1.19e-05	7.75e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	1.19e-05	7.7e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	1.17e-05	7.63e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.17e-05	7.57e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	1.16e-05	7.52e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.15e-05	7.48e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—INS—polycystic ovary syndrome	1.15e-05	7.48e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	1.15e-05	7.45e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	1.15e-05	7.44e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	1.13e-05	7.32e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.09e-05	7.08e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.08e-05	7.03e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	1.04e-05	6.77e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	1.04e-05	6.73e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.01e-05	6.53e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	1e-05	6.51e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	1e-05	6.51e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	9.68e-06	6.29e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	9.63e-06	6.26e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.52e-06	6.19e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	9.39e-06	6.1e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	9.32e-06	6.05e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	9.31e-06	6.05e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.85e-06	5.75e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	8.77e-06	5.7e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.02e-06	5.21e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	7.67e-06	4.98e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.49e-06	4.87e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	7.12e-06	4.63e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.55e-06	4.25e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.08e-06	3.95e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	5.55e-06	3.6e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	5.18e-06	3.37e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	4.53e-06	2.94e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	4.21e-06	2.73e-05	CbGpPWpGaD
